argenx SE | Investor Presentation Deck | 25 slides · page 15 of 25
The slide outlines a clinical trial protocol with a 1-3 week screening phase followed by a 30-week treatment period.
Conference presentation · timeline · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 list 1/1 source-note 1/1 title 1/1
Components 5
primary process bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.